Trial · NCT03697720
Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain
NCT03697720, Phase 4, Completed, Endeavor Health; results first posted 2023-10-18
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain. Trials, record NCT03697720. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03697720
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain
- NCT number
- NCT03697720
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 26 participants, actual
- Lead sponsor
- Endeavor Health
- Conditions
- Dysmenorrhea, Pain
- Interventions
- Naproxen
- First posted
- 2018-10-05
- Last updated
- 2023-10-18
- Results first posted
- 2023-10-18
- Limitations and caveats
- There was some loss to follow-up. We did not systematically query for adverse events.
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Menstrual Pain | 6-8 months | Score on a scale. Specifically, we used a Numeric Rating Scale (NRS)- 0 through 10 scale with 0 being no pain and 10 worst pain imaginable. Results for the worst menstrual pain score on an NRS from the 6-8 mth menstrual pain diary will be compared to baseline pretreatment diary worst pain score. |
| Primary | Change in Participant Bladder Pain Sensitivity From Baseline | 6-8 months | Score on a scale. Specifically, we used a Visual Analog Scale- 0 through 100 scale with 0 being no pain and 100 worst pain imaginable. Results from the visual analog scale (VAS) of the bladder filling test at the baseline and 6-8 mph followup visit will be compared to determine if naproxen treatment of menstrual pain affected bladder pain. Bladder pain ratings at first urge will be used at the outcome measure. |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Menstrual Pain | 6-8 months | Some participant data were missing due to attrition | score on a scale | MEAN |
| PRIMARY | Change in Participant Bladder Pain Sensitivity From Baseline | 6-8 months | Some participant data were missing due to attrition. | score on a scale | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Menstrual Pain | Primary Dysmenorrhea | 4.1 | Standard Deviation 2.4 | score on a scale | |
| Change in Participant Bladder Pain Sensitivity From Baseline | Primary Dysmenorrhea | 10.7 | Standard Deviation 10.6 | score on a scale |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Primary Dysmenorrhea | 26 | |
| Overall Study | COMPLETED | Primary Dysmenorrhea | 19 | |
| Overall Study | NOT COMPLETED | Primary Dysmenorrhea | 7 |
Source ClinicalTrials.gov
Adverse events1
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dyspepsia grade 1 | Gastrointestinal disorders | Primary Dysmenorrhea | 1 | 26 | 1 |
Source ClinicalTrials.gov
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Primary Dysmenorrhea | 0 | 26 |
| Total, other adverse events | Primary Dysmenorrhea | 1 | 26 |
| Total, serious adverse events | Primary Dysmenorrhea | 0 | 26 |
Source ClinicalTrials.gov
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03697720
GET https://conductscience.org/api/trials/v1/NCT03697720/registered